3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)

A new class of FLT3 inhibitors has been identified based on the 3-phenyl-1H-5-pyrazolylamine scaffold. The structure–activity relationships led to the discovery of two carbamate series, and some potent compounds within these two series exhibited better growth inhibition of FLT3-mutated MOLM-13 cells...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 22; no. 14; pp. 4654 - 4659
Main Authors Hsu, John T.-A., Yeh, Teng-Kuang, Yen, Shih-Chieh, Chen, Chiung-Tong, Hsieh, Shu-Yi, Hsu, Tsu, Lu, Cheng-Tai, Chen, Chun-Hwa, Chou, Ling-Hui, Chiu, Ching-Hui, Chang, Yun-I, Tseng, Ya-Ju, Yen, Kuei-Rong, Chao, Yu-Sheng, Lin, Wen-Hsing, Jiaang, Weir-Torn
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 15.07.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new class of FLT3 inhibitors has been identified based on the 3-phenyl-1H-5-pyrazolylamine scaffold. The structure–activity relationships led to the discovery of two carbamate series, and some potent compounds within these two series exhibited better growth inhibition of FLT3-mutated MOLM-13 cells than FLT3 inhibitors sorafenib (2) and ABT-869 (3). In particular, compound 8d exhibited the ability to regress tumors in mouse xenograft model using MOLM-13 cells.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2012.05.116
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2012.05.116